Cash Dividend On The Way From Five Oaks Investment Corp's Series A Cumulative Redeemable Preferred Stock

On 5/13/15, Five Oaks Investment Corp's 8.75% Series A Cumulative Redeemable Preferred Stock (OAKS.PRA) will trade ex-dividend, for its monthly dividend of $0.1823, payable on 5/27/15. As a percentage of OAKS.PRA's recent share price of $25.25, this dividend works out to approximately 0.72%, so look for shares of OAKS.PRA to trade 0.72% lower — all else being equal — when OAKS.PRA shares open for trading on 5/13/15. On an annualized basis, the current yield is approximately 8.66%, which compares to an average yield of 6.99% in the "Real Estate" preferred stock category, according to Preferred Stock Channel.

START SLIDESHOW:
Click here to learn which S.A.F.E. dividend stocks also have preferred shares that should be on your radar screen »

As of last close, OAKS.PRA was trading at a 1.00% premium to its liquidation preference amount, versus the average premium of 2.55% in the "Real Estate" category. The chart below shows the one year performance of OAKS.PRA shares, versus OAKS:

Performance Comparison Chart

Below is a dividend history chart for OAKS.PRA, showing historical dividends prior to the most recent $0.1823 on Five Oaks Investment Corp's 8.75% Series A Cumulative Redeemable Preferred Stock:

OAKS.PRA+Dividend+History+Chart

In Monday trading, Five Oaks Investment Corp's 8.75% Series A Cumulative Redeemable Preferred Stock ( OAKS.PRA) is currently trading flat on the day, while the common shares ( OAKS) are up about 1.4%.

More from Stocks

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

3 Great Stock Market Sectors Millennials Should Invest In

3 Great Stock Market Sectors Millennials Should Invest In

Why Millennials Are Ditching Stocks for ETFs

Why Millennials Are Ditching Stocks for ETFs

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says